Elevated serum CA 19-9 in association with Hashimoto thyroiditis.

Area of Science:

• Oncology
• Endocrinology
• Clinical Diagnostics

Background:

• Tumor markers are crucial in clinical practice for cancer detection and monitoring.
• Elevated tumor markers can be associated with both malignant and benign conditions, necessitating careful interpretation.
• Awareness of these associations aids in avoiding unnecessary investigations while ensuring timely diagnosis of malignancies.

Observation:

• A 58-year-old woman presented with weight loss and elevated carbohydrate antigen 19-9 (CA19-9).
• Investigations revealed Hashimoto thyroiditis as the diagnosis, with no evidence of underlying malignancy.
• The patient's CA19-9 levels normalized upon achieving a euthyroid state.

Findings:

• The study demonstrates a case where elevated CA19-9 was associated with Hashimoto thyroiditis, a benign autoimmune disorder.
• Malignancy investigations were negative, indicating that CA19-9 elevation in this instance was not indicative of cancer.
• Resolution of the thyroiditis and restoration of the euthyroid state correlated with the normalization of CA19-9 levels.

Implications:

• This case underscores the importance of considering benign conditions, such as Hashimoto thyroiditis, in the differential diagnosis of elevated CA19-9.
• Accurate interpretation of tumor markers can prevent unnecessary, costly, and potentially invasive investigations in patients with benign diseases.
• Clinicians should integrate clinical presentation and other diagnostic findings to appropriately manage patients with elevated tumor markers.